[HTML][HTML] Infection-and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023
R Kinoshita, S Miyamoto, S Sakuraba… - Emerging Infectious …, 2024 - ncbi.nlm.nih.gov
We assessed SARS-CoV-2 seroprevalence in Japan during July–August 2023, with a focus
on 2 key age groups, 0–15 and> 80 years. We estimated overall seroprevalence of 45.3 …
on 2 key age groups, 0–15 and> 80 years. We estimated overall seroprevalence of 45.3 …
Deep Watcher: A Surveillance System Using Deep Learning for the COVID-19 Pandemic
R Kulshreshtha, J Jayapradha - … on Advances in Computing and Data …, 2023 - Springer
Several solutions have been proposed to combat the COVID-19 pandemic. In the absence
or limited availability of medical resources, World Health Organization has recommended …
or limited availability of medical resources, World Health Organization has recommended …